HRT Lawsuit – Pfizer Puts Aside $772 Million for Litigation

by Laura Ramirez on July 10, 2011

The HRT lawsuit against Pfizer Inc. for the drug PremPro (which was originally manufactured by Wyeth, a company that Pfizer bought in 2009) is about to go into the settlement phase. Athough Pfizer has set aside more than three-quarters of a million dollars for settlements, experts predict that it will cost them much more. Approximately, one-third of all claims have already been settled.

Pharmaceutical giant Pfizer Inc. acknowledged it faces huge settlements for hormone-replacement therapy drugs. The company said in an SEC filing that it has put aside $772 million to resolve claims. Experts expect the amount to be much higher, and so does Pfizer. The company wrote that the amount it put aside is “the minimum expected costs to resolve all of the other outstanding..”…

At one time, more than six million women around the world were taking PremPro which was given to alleviate menopause symptoms like hot flashes and mood swings.

Paying outstanding claims will help Pfizer take responsibility for the actions of Wyeth and finally move past this longstanding HRT lawsuit.

>Click here to read original article

Be Sociable, Share!

Previous post:

Next post: